Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: DDS stock price vs DE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DE's multiple
Needs DE P/E.
Implied fair value · at DDS's multiple
Needs DDS P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: DDS FY 2026 (ended Jan 31, 2026) · DE FY 2025 (ended Nov 2, 2025). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 104% equity / -4% debt · EV / Revenue 1.37x · EV / EBITDA 12.93x
Capital structure 93% equity / 7% debt · EV / Revenue 4.18x · EV / EBITDA 14.81x
DE carries the larger enterprise value at $191.10B against $8.99B; DDS trades on the lower EV / Revenue multiple (1.37x vs 4.18x); DDS on the lower EV / EBITDA (12.93x vs 14.81x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
DILLARD’S, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
DEERE & CO · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-0.23x
0.53x
Net debt / EBITDA
Leverage against operating earnings
-1.82x
0.32x
Cash and equivalents
Liquid reserves on the balance sheet
$861.46M
$9.69B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
-$402.20M
$13.80B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
